LTC2330892I2 - Gydymo būdai panaudojant vaistus - amoniako gaudykles - Google Patents

Gydymo būdai panaudojant vaistus - amoniako gaudykles

Info

Publication number
LTC2330892I2
LTC2330892I2 LTPA2016041C LTPA2016041C LTC2330892I2 LT C2330892 I2 LTC2330892 I2 LT C2330892I2 LT PA2016041 C LTPA2016041 C LT PA2016041C LT PA2016041 C LTPA2016041 C LT PA2016041C LT C2330892 I2 LTC2330892 I2 LT C2330892I2
Authority
LT
Lithuania
Prior art keywords
drugs
treatment methods
traps
ammonia
ammonia traps
Prior art date
Application number
LTPA2016041C
Other languages
English (en)
Original Assignee
Horizon Therapeutics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41255339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC2330892(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Horizon Therapeutics, Llc filed Critical Horizon Therapeutics, Llc
Publication of LTPA2016041I1 publication Critical patent/LTPA2016041I1/lt
Publication of LTC2330892I2 publication Critical patent/LTC2330892I2/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
LTPA2016041C 2008-04-29 2016-12-16 Gydymo būdai panaudojant vaistus - amoniako gaudykles LTC2330892I2 (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4883008P 2008-04-29 2008-04-29
US9323408P 2008-08-29 2008-08-29
PCT/US2009/030362 WO2009134460A1 (en) 2008-04-29 2009-01-07 Methods of treatment using ammonia-scavenging drugs

Publications (2)

Publication Number Publication Date
LTPA2016041I1 LTPA2016041I1 (lt) 2017-01-10
LTC2330892I2 true LTC2330892I2 (lt) 2018-06-11

Family

ID=41255339

Family Applications (1)

Application Number Title Priority Date Filing Date
LTPA2016041C LTC2330892I2 (lt) 2008-04-29 2016-12-16 Gydymo būdai panaudojant vaistus - amoniako gaudykles

Country Status (12)

Country Link
US (2) US8642012B2 (lt)
EP (2) EP3133396B1 (lt)
CA (1) CA2735218A1 (lt)
CY (3) CY1118543T1 (lt)
DK (1) DK2330892T3 (lt)
GB (1) GB2470310A (lt)
HU (1) HUS1600057I1 (lt)
LT (1) LTC2330892I2 (lt)
NL (1) NL300854I2 (lt)
NO (1) NO2016023I2 (lt)
PL (1) PL3133396T3 (lt)
WO (1) WO2009134460A1 (lt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3133396T3 (pl) 2008-04-29 2019-03-29 Horizon Therapeutics, Llc Sposób leczenia z zastosowaniem leków wychwytujących amoniak
WO2011011781A1 (en) 2009-07-24 2011-01-27 Baylor College Of Medicine Methods of modulation of branched chain acids and uses thereof
DK2760479T3 (en) 2011-09-30 2017-07-17 Horizon Therapeutics Llc Nitrogen-removing drug for use in a method of treating a nitrogen retention disorder
CN104540507A (zh) 2012-04-20 2015-04-22 海波龙治疗公司 苯乙酸前药的治疗性监测方法
US9289406B2 (en) * 2012-11-21 2016-03-22 Horizon Therapeutics, Inc. Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy
ES2746999T3 (es) 2013-10-14 2020-03-09 Immedica Pharma Ab Métodos de tratamiento de trastornos del ciclo de la urea
EP3782610A1 (en) 2013-11-14 2021-02-24 Ultragenyx Pharmaceutical Inc. Solid compositions of triglycerides and uses tehreof
JP6302091B2 (ja) 2014-04-30 2018-03-28 ザ・ジョンズ・ホプキンス・ユニバーシティー デンドリマー組成物および眼の疾患の処置におけるその使用
US20170087113A1 (en) * 2014-06-04 2017-03-30 Horizon Therapeutics, Llc Methods for treating urea cycle disorders to prevent hyperammonemic crises by controlling blood ammonia levels
EP3180031A1 (en) 2014-08-13 2017-06-21 The Johns Hopkins University Selective dendrimer delivery to brain tumors
CA3003589C (en) 2015-10-29 2021-12-07 The Johns Hopkins University Dendrimer compositions and methods for treatment of peroxisomal disorders and leukodystrophies
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
WO2018170234A1 (en) 2017-03-15 2018-09-20 President And Fellows Of Harvard College Methods and compositions for treating cancer
CN118105471A (zh) * 2017-05-24 2024-05-31 托埃瑞斯有限责任公司 谷氨酰胺合成酶用于治疗高氨血症的用途
BR112019028097A2 (pt) 2017-06-28 2020-07-28 Baylor College Of Medicine terapia combinada para tratar distúrbios do ciclo de ureia
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
EP3946029A4 (en) 2019-03-28 2022-12-21 Zoll Medical Corporation Systems and methods for providing drug prescription information with monitored cardiac information
AU2020396561A1 (en) 2019-12-04 2022-07-14 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284647A (en) * 1980-03-31 1981-08-18 The Johns Hopkins University Process for waste nitrogen removal
DE69612755T2 (de) 1995-02-07 2001-08-23 Brusilow Enterprises, Llc Triglyceride und ethylester von phenylalkansäuren und phenylalkensäuren zur behandlung verschiedener erkrankungen
DE19805854C1 (de) * 1998-02-13 1999-05-12 Claas Usines France Schalteinrichtung für Schneidmesser
US6219567B1 (en) * 1999-06-21 2001-04-17 Cardiox Corporation Monitoring of total ammoniacal concentration in blood
US20040229948A1 (en) 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
PL1824563T3 (pl) 2004-11-26 2010-07-30 Ucl Business Plc Kompozycje zawierające ornitynę i fenylooctan lub fenylomaślan do leczenia encefalopatii wątrobowej
US20060135612A1 (en) * 2004-12-17 2006-06-22 U.S. Department Of Veterans Affairs Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent
EP2237684A2 (en) 2008-01-08 2010-10-13 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
GB2465250B (en) 2008-08-29 2011-01-26 Ucyclyd Pharma Inc Dosing and monitoring patients on nitrogen-scavenging drugs
PL3133396T3 (pl) 2008-04-29 2019-03-29 Horizon Therapeutics, Llc Sposób leczenia z zastosowaniem leków wychwytujących amoniak

Also Published As

Publication number Publication date
DK2330892T3 (en) 2016-08-22
NL300854I2 (lt) 2017-02-02
NO2016023I2 (no) 2016-12-27
CY1118543T1 (el) 2017-06-28
EP2330892B1 (en) 2016-06-29
PL3133396T3 (pl) 2019-03-29
NO2016023I1 (no) 2016-12-14
HUS1600057I1 (hu) 2017-01-30
US8642012B2 (en) 2014-02-04
EP3133396B1 (en) 2018-09-05
GB201013468D0 (en) 2010-09-22
CA2735218A1 (en) 2009-11-05
WO2009134460A1 (en) 2009-11-05
EP2330892A1 (en) 2011-06-15
CY2016053I1 (el) 2017-06-28
EP3133396A1 (en) 2017-02-22
EP2330892A4 (en) 2012-01-11
LTPA2016041I1 (lt) 2017-01-10
GB2470310A (en) 2010-11-17
US20100008859A1 (en) 2010-01-14
CY1121288T1 (el) 2020-05-29
US20140256807A1 (en) 2014-09-11
CY2016053I2 (el) 2017-06-28

Similar Documents

Publication Publication Date Title
LTPA2016041I1 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
BRPI0910854A2 (pt) métodos de tratamento
BRPI0910259A2 (pt) métodos de tratamento de inflamação
BRPI0917575A2 (pt) métodos de tratamento de talassemia
EP2320045A4 (en) APPARATUS FOR TREATING EXHAUST GAS
DK2330887T3 (da) Behandlingsindretning
DK3750552T5 (da) Gdf-fælder
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
EP2296593A4 (en) MEDICAL HEAD COVER
FIC20240018I1 (fi) Vamoroloni
BRPI0919127A2 (pt) métodos para tratamento de água
BRPI0911625A2 (pt) Métodos
BRPI0915822A2 (pt) dispositivo médico
BRPI0923527A2 (pt) métodos de preparo de fungicidas
DK2173831T3 (da) Brøndbehandling
HUE055421T2 (hu) Stimuláló berendezés
EP3381471C0 (en) PAIN TREATMENT
FI20095184L (fi) Houkutin
IT1392349B1 (it) Dispositivo massaggiatore
HRP20160577T1 (hr) Liječenje osteoartritisa
PT3133396T (pt) Métodos de tratamento utilizando fármacos eliminadores de amoníaco
BRPI0916990A2 (pt) Combinações inseticidas
EP2266520A4 (en) Massage machine
BRPI0922008A2 (pt) compostos e respectivos metodos de preparação
FR2937843B1 (fr) Paravent medical